Oncolytics Biotech, Inc. (ONCY)
0.8778
-0.09
(-9.35%)
USD |
NASDAQ |
Feb 03, 16:00
1.00
+0.12
(+13.92%)
After-Hours: 07:56
Oncolytics Biotech Research and Development Expense (TTM) : 13.59M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 29.72M |
| Edesa Biotech, Inc. | 3.669M |
| Lexaria Bioscience Corp. | 6.957M |
| Xenon Pharmaceuticals, Inc. | 270.15M |
| ProMIS Neurosciences, Inc. | 28.34M |